We detected an increase in the phosphorylated form of eIF2α and in the cleaved caspase-3 fraction, indicating the eIF2α signaling pathway is upregulated in these prostate tumor cells following targeted IL-27 gene delivery, leading to apoptosis induction. Here, EIF2A is linked to prostate neoplasm.